Women at risk for hip fracture following decline in bisphosphonate use.

被引：0
|
作者：
Perraillon, Marcelo Coca
Bradley, Cathy J.
机构：
[1] Univ Colorado, Anschutz Med Campus, Aurora, CO USA
[2] Univ Colorado, Ctr Canc, Denver, CO 80262 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 27期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1200/JCO.2019.37.27_suppl.239
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
239
引用
收藏
页数：1
相关论文
共 50 条
  • [21] BISPHOSPHONATE TREATMENT AND MORTALITY RISK REDUCTION AFTER OSTEOPOROTIC HIP FRACTURE
    Diehl, Maria
    Beratarrechea, Andrea
    Pace, Natalia
    Saimovici, Javier
    Trossero, Adriana
    Perman, Gaston
    Plantalech, Luisa
    [J]. ACTUALIZACIONES EN OSTEOLOGIA, 2013, 9 (02) : 154 - 164
  • [22] Risk of Hip Fracture after Bisphosphonate Discontinuation: Implications for a Drug Holiday
    Curtis, J. R.
    Westfall, A. O.
    Cheng, H.
    Delzell, E.
    Saag, K. G.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S122 - S123
  • [23] Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary
    Fisher, Alex
    Martin, Jodie
    Srikusalanukul, Wichat
    Davis, Michael
    [J]. CLINICAL INTERVENTIONS IN AGING, 2010, 5 : 355 - 362
  • [24] Risk of hip fracture after bisphosphonate discontinuation: Implications for a drug holiday
    Curtis, Jeffrey R.
    Westfall, Andrew
    Cheng, Hong
    Delzell, Elizabeth
    Saag, Kenneth
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S740 - S740
  • [25] Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday
    Curtis, J. R.
    Westfall, A. O.
    Cheng, H.
    Delzell, E.
    Saag, K. G.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2008, 19 (11) : 1613 - 1620
  • [26] Disuse osteopenia following leg fracture in postmenopausal women: Implications for HIP fracture risk and fracture liaison services
    Hopkins, S. J.
    Toms, A. D.
    Brown, M.
    Appleboam, A.
    Knapp, K. M.
    [J]. RADIOGRAPHY, 2018, 24 (02) : 151 - 158
  • [27] ORAL BISPHOSPHONATE USE AFTER HIP FRACTURE IS ASSOCIATED WITH REDUCED MORTALITY
    Beaupre, L. A.
    Morrish, D.
    Hanley, D. A.
    Juby, A. G.
    Maksymowych, W. P.
    Bell, N. R.
    Majumdar, S. R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 337 - 337
  • [28] ANTICONVULSANT USE AND RISK OF HIP FRACTURE
    RAY, WA
    GRIFFIN, MR
    [J]. CLINICAL RESEARCH, 1987, 35 (03): : A359 - A359
  • [29] RISK OF HIP FRACTURE FOLLOWING HOSPITAL DISCHARGE
    GRIFFIN, MR
    RAY, WA
    [J]. CLINICAL RESEARCH, 1988, 36 (03): : A338 - A338
  • [30] A population-based case–control study: proton pump inhibition and risk of hip fracture by use of bisphosphonate
    Joongyub Lee
    KyungEun Youn
    Nam-Kyong Choi
    Jin-Ho Lee
    DongYoon Kang
    Hong-Ji Song
    Byung-Joo Park
    [J]. Journal of Gastroenterology, 2013, 48 : 1016 - 1022
12345